OQROGet OQRO Pro
Insider trade

Denali Therapeutics (DNLI)Chief Medical Officer sold ~$12K

Carole Ho, Chief Medical Officer at Denali Therapeutics, sold ~$12K of Denali Therapeutics shares.

~$12K
Approx. value · 806 sh @ $14.64
217K
Holds after · shares reported
Traded
Aug 13, 2025
Filed
Aug 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 9, 2025InsiderCEO sold ~$7.43M of DNLI shares in the open market
  2. Aug 12, 2025Insider · 2 peopleInsiders: 2 sales (~$80K)
  3. Aug 13, 2025 · this disclosureInsiderOfficer sold ~$12K of DNLI shares in the open market

What came next

  1. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  2. Dec 4, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  3. Dec 9, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Denali Therapeutics

OQRO holds no insider, Congress, fund or contract record for Denali Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNLI page.

Other recent filings by Carole Ho, Chief Medical Officer

The full history of Carole Ho, Chief Medical Officer is on the profile page.

How this filing works

Other disclosures at Denali Therapeutics

Everything OQRO holds on this company is on its DNLI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data